GlassScriptPhysician profile
Amber Sharee Baker
NPI 1487136883
$1,563.31
in general payments reported to CMS, 2019-2025
18 companies · $691 in 2025
The $691 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $365 · 2023: $293 · 2024: $215 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $267.12 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $255.18 | 2023-2025 | Libtayo, Dupixent |
| Abbvie INC. | $222.76 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $150.41 | 2023-2025 | Blu-U, Odomzo |
| Incyte Corporation | $126.96 | 2024-2025 | Opzelura |
| Lilly USA, LLC | $83.45 | 2024-2025 | Taltz, Ebglyss, Zepbound |
| Pfizer INC. | $80.82 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $65.97 | 2023 | Sotyktu |
| Organogenesis INC. | $65.10 | 2025 | Puraply Wound Matrix, Novachor |
| Ucb, INC. | $45.70 | 2025 | Bimzelx |
| Mallinckrodt Hospital Products INC. | $38.85 | 2025 | Acthar |
| Leo Pharma INC. | $30.76 | 2025 | Adbry |
| Kerecis Limited | $26.96 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbott Laboratories | $26.04 | 2023 | Cardiomems |
| Convatec INC. | $23.11 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $20.65 | 2024 | |
| Bioventus LLC | $17.33 | 2022 | |
| Journey Medical Corporation | $16.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.